详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

SEMA4C as a Relapse Biomarker in Breast Cancer

66| 认领 | 链接全文 |

文献详情

编号/登记号：

注册时间：

研究开始时间：

研究结束时间：

项目类型：

本院角色：

多中心研究：

招募状态：

研究疾病/适应症：

研究类型：

研究负责人：

研究单位： [1]Tongji Hospital [2]Hubei Cancer Hospital [3]Qilu Hospital of Shandong University [4]Wuhan Central Hospital [5]Xiangyang Central Hospital [6]The First People's Hospital of Jingzhou [7]The First Affiliated Hospital with Nanjing Medical University

研究目的：

Breast cancer remains the most common cancer in women worldwide. Semaphorin4C (SEMA4C) has previously been identified as a highly expressed protein by breast cancer-associated lymphatic endothelial cells (LECs). The objective of this study is to investigate SEMA4C's potential role as an early relapse biomarker in breast cancer.

资源点击量：434 今日访问量：0 总访问量：419 更新日期：2025-05-01 建议使用谷歌、火狐浏览器 常见问题